Clinical use of botulinum toxin. National Institutes of Health Consensus Development Conference Statement, November 12-14, 1990.
D001764:Blepharospasm / Q000188:drug therapy; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004421:Dystonia / Q000188:drug therapy; D005152:Facial Muscles; D006801:Humans; D009135:Muscular Diseases / Q000188:drug therapy; D013035:Spasm / Q000188:drug therapy; D014481:United States; D014832:Voice Disorders / Q000188:drug therapy
D001905:Botulinum Toxins